VNA
EW icon

Valley National Advisers’s Edwards Lifesciences EW Stock Holding History

Valley National Advisers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
1,218
+1,177
+2,871% +$98.6K 0.01% 322
2026
Q1 		$3K Buy
41
+8
+24% +$660 ﹤0.01% 731
2025
Q4 		$2K Buy
33
+18
+120% +$1.48K ﹤0.01% 770
2025
Q3 		$1K Sell
15
-5
-25% -$391 ﹤0.01% 783
2025
Q2 		$1K Sell
20
-1
-5% -$75 ﹤0.01% 769
2025
Q1 		$1K Buy
+21
New +$1.5K ﹤0.01% 763
2024
Q3 		– Sell
-3,760
Closed -$347K – 874
2024
Q2 		$347K Buy
3,760
+1,083
+40% +$95.9K 0.05% 190
2024
Q1 		$255K Buy
2,677
+152
+6% +$12.8K 0.04% 222
2023
Q4 		$192K Buy
2,525
+305
+14% +$21.2K 0.03% 237
2023
Q3 		$154K Buy
2,220
+20
+0.9% +$1.61K 0.03% 260
2023
Q2 		$208K Buy
2,200
+1,038
+89% +$90.2K 0.04% 236
2023
Q1 		$103K Buy
1,162
+13
+1% +$1.02K 0.02% 294
2022
Q4 		$89K Sell
1,149
-36
-3% -$2.77K 0.02% 316
2022
Q3 		$102K Hold
1,185
– – 0.02% 294
2022
Q2 		$117K Buy
1,185
+875
+282% +$90.6K 0.02% 267
2022
Q1 		$36K Hold
310
– – 0.01% 432
2021
Q4 		$40K Hold
310
– – 0.01% 398
2021
Q3 		$35K Sell
310
-26
-8% -$2.97K 0.01% 388
2021
Q2 		$35K Hold
336
– – 0.01% 390
2021
Q1 		$28K Sell
336
-300
-47% -$25.4K 0.01% 401
2020
Q4 		$58K Hold
636
– – 0.01% 307
2020
Q3 		$51K Hold
636
– – 0.01% 286
2020
Q2 		$44K Sell
636
-2,373
-79% -$169K 0.01% 304
2020
Q1 		$189K Buy
3,009
+219
+8% +$15.8K 0.05% 175
2019
Q4 		$217K Buy
2,790
+600
+27% +$46.9K 0.05% 190
2019
Q3 		$161K Hold
2,190
– – 0.04% 202
2019
Q2 		$135K Sell
2,190
-1,101
-33% -$66.6K 0.04% 212
2019
Q1 		$210K Buy
+3,291
New +$188K 0.06% 168

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Valley National Advisers's EW Position: Q2 2026 in Review

Valley National Advisers increased its Edwards Lifesciences (EW) stake by 2,871% in Q2 2026, buying an estimated $98.6K and bringing the position to 1,218 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #322.

Valley National Advisers first reported a position in EW in Q1 2019 and has held it in 28 quarters since. The position peaked at $347K in Q2 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Valley National Advisers held 1,218 shares of Edwards Lifesciences worth $110K as of Q2 2026.
  • Valley National Advisers bought 1,177 Edwards Lifesciences shares in Q2 2026, an estimated $98.6K.
  • Edwards Lifesciences made up 0.01% of Valley National Advisers's portfolio in Q2 2026, its #322 holding.
  • Valley National Advisers first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 28 quarters since.
  • Valley National Advisers's Edwards Lifesciences position peaked at $347K in Q2 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.